GRIP
Global Research in Paediatrics
| Coordinatore | AZIENDA OSPEDALIERA DI PADOVA
Organization address
address: Via Giustiniani 1 contact info |
| Nazionalità Coordinatore | Italy [IT] |
| Totale costo | 12˙668˙685 € |
| EC contributo | 9˙999˙999 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2010-single-stage |
| Funding Scheme | NoE |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-01-01 - 2015-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
AZIENDA OSPEDALIERA DI PADOVA
Organization address
address: Via Giustiniani 1 contact info |
IT (PADOVA) | coordinator | 335˙297.75 |
| 2 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 1˙065˙134.00 |
| 3 |
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE
Organization address
address: VIA LUIGI PORTA 14 contact info |
IT (PAVIA) | participant | 1˙017˙786.25 |
| 4 |
FONDAZIONE PENTA-FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV-ONLUS
Organization address
address: CORSO STATI UNITI 4 contact info |
IT (PADOVA) | participant | 1˙015˙040.00 |
| 5 |
Nome Ente NON disponibile
Organization address
address: STENBACKINKATU 9 contact info |
FI (HELSINKI) | participant | 797˙560.00 |
| 6 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 730˙104.00 |
| 7 |
THE UNIVERSITY OF LIVERPOOL
Organization address
address: Brownlow Hill, Foundation Building 765 contact info |
UK (LIVERPOOL) | participant | 649˙152.00 |
| 8 |
OSPEDALE PEDIATRICO BAMBINO GESU
Organization address
address: PIAZZA SAN ONOFRIO 4 contact info |
IT (ROMA) | participant | 600˙762.00 |
| 9 |
The Hospital for Sick Children
Organization address
address: University Avenue 555 contact info |
CA (Toronto) | participant | 599˙540.01 |
| 10 |
BRIGHTON COLLABORATION FOUNDATION
Organization address
address: SPITALSTRASSE 33 contact info |
CH (BASEL) | participant | 530˙997.00 |
| 11 |
FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
Organization address
address: PLAZA ASUA 1 contact info |
ES (SONDIKA) | participant | 433˙072.75 |
| 12 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 421˙828.00 |
| 13 |
European Medicines Agency
Organization address
address: Westferry Circus 7 contact info |
UK (London) | participant | 293˙911.50 |
| 14 |
UNIVERSITEIT LEIDEN
Organization address
address: RAPENBURG 70 contact info |
NL (LEIDEN) | participant | 269˙847.59 |
| 15 |
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
Organization address
address: Cranmer Terrace contact info |
UK (LONDON) | participant | 261˙400.00 |
| 16 |
National Center for Child Health and Development
Organization address
address: Okura 2-10-1 contact info |
JP (Tokyo) | participant | 236˙662.00 |
| 17 |
WORLD HEALTH ORGANIZATION.
Organization address
address: Avenue Appia 20 contact info |
CH (GENEVE) | participant | 236˙577.00 |
| 18 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 235˙288.00 |
| 19 |
INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA
Organization address
address: Aleja Dzieci Polskich 20 contact info |
PL (WARSZAWA) | participant | 146˙289.94 |
| 20 |
VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES
Organization address
address: Vredehofstraat 31 contact info |
NL (SOEST) | participant | 123˙750.00 |
| 21 |
"THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON"
Organization address
address: Brunswick Square 29-39 contact info |
UK (LONDON) | participant | 0.00 |
| 22 |
United States Department of Health and Human Services
Organization address
address: Independence Avenue S. W. 200 contact info |
US (Washington D.C.) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Paediatric drugs (PD) lack appropriate testing. Most drugs have inadequate information about dosing regimen, dose adjustment and how to administer them. These are longstanding problems that unquestionably require concerted efforts at the international level. Both the US and the EU have introduced paediatric legislation that facilitates participation of children in research and pharmaceutical innovation but initiatives are not always coordinated and often different approaches are used to deal with the same problems. The main aim of GRiP will be to implement an infrastructure matrix to stimulate and facilitate the development and safe use of medicine in children. This implementation entails active coordination of knowledge management efforts and integrated use of existing research capacity, whilst reducing the fragmentation and duplication of activities. The consortium will primarily focus on: 1) development of a Paediatric Clinical Pharmacology Training Program; 2) Validation and harmonisation of research tools specific for paediatrics; 3) Sharing of strategies and plans; 4) Use of ongoing/planned research studies to evaluate the feasibility of proposed research tools and strategies. GRiP brings together an exceptional range of high quality leaders and stakeholders that are very active in the context of EU and US paediatric medicines research. GRiP will mobilize 21 institutions as partners and at least another 16 major networks that represent several hundreds of clinical sites and a total of more than 1000 researchers across Europe, the US and Asia. The integration of the WHO, EMA and the NIH-NICHD associated networks, including the FDA, will be a major asset not just for an effective implementation of the network activities without duplication, but also for the rapid translation of GRiP deliverables into practice. This partnership will work closely with families to provide children with safe and effective medicines.'
Introduzione (Teaser)
Researchers are developing a coordinated international approach to the development of safe and effective paediatric drugs.